Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

The study was conducted without registration as per hospital procedures

Funding Statement

Hospital Universitario Fundacion Alcorcon supported the study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

HUFA IRB provided approval of the protocol on January 27th

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes